Translation and Validation of the COMM and ASI-SR
RecruitingNCT06084520
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this observational study is to translate the COMM (Current opinion misuse measure) form and validate it using the ASI-SR (Addiction severity score-self report)in a Swedish population of pain patients treated with opioids. The secondary aim is to investigate acceptability of the instrument in a Swedish population of pain patients with long-term opioid treatment (LOT). The tertiary aim is to investigate the prevalence of alcohol and illicit substance use in a Swedish population of pain patients with LOT.
Study details
- Official title
- Translation and Validation of the COMM and ASI-SR - Instruments for Assessing Substance Use Disorder Development in a Swedish Population of Patients With Long-term Pain Treated With Opioids
- Conditions
- Opioid Use
- Opioid Use Disorder
- Alcohol Use Disorder
- Pain, Chronic
- Interventions
- Diagnostic test: Current Opioid Misuse Measure (COMM)-SWE
- Diagnostic test: Oral fluid drug test
- Diagnostic test: PETh
- Diagnostic test: ASI-SR
- Diagnostic test: AUDIT
- Diagnostic test: DUDIT
- Diagnostic test: Brief Pain Inventory - BPI
- Diagnostic test: Patient Global Impression of Change PGIC
- Diagnostic test: GAD-7
- Diagnostic test: Patient Health questionnaire (PHQ9)
- Diagnostic test: DBS - cannabis test
- Other: Sample of Blood for later DNA and immunological analysis in future studies
- Sponsor
- Uppsala University
- Collaborators
- The Kamprad Family Foundation for Entrepreneurship, Research & Charity
- Start date
- 2023-12-01
- Primary completion
- 2025-12-31
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Sweden
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: Intervention group: * Patients with long-term, non-cancer-related pain (\>3 months) at least 3 days a week * opioid treatment for at least 1 month during last 6 months * age 18-75 years * fluent in spoken and written Swedish. Control group: * Patients with long-term, non-cancer-related pain (\>3 months) at least 3 days a week * no opioid treatment at inclusion and during last 3 months * age 18-75 years * fluent in spoken and written Swedish Exclusion Criteria: * ongoing diseases or conditions that prevents the patient from completing to the study according to the doctor's assessment * serious cognitive disorder that makes answering the questions impossible. - - ongoing or treated cancer in the last 10 years * Insufficient knowledge of Swedish
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06084520